DNAvaccine.com Presents: Optimizing Gene Expression/Performance using GeneGPS™ with Dr. Mark Welch of DNA2.0
Join us for a Webinar on May 22
Space is limited.
Reserve your Webinar seat now at:
Gene synthesis allows researchers to tailor gene sequences for optimal utility for any application. However, the relationship between gene sequence and expression is complex and depends on a wide range of sequence variables. DNA2.0 uses a systematic engineering approach, GeneGPS™, to navigate these variables with a minimal number of test genes to optimize performance. Application of this approach with a variety of protein targets and expression hosts will be described.
Dr. Mark Welch
Director, Gene Design
Menlo Park, CA
Dr. Mark Welch studied for his undergraduate degree at the University of California at Santa Cruz and received his Ph.D. at the University of Colorado at Boulder. From 1998 to 2002 Dr. Welch worked as a staff scientist at Maxygen in the development and application of directed biomolecule evolution. He then pursued work in the area of rational and combinatorial protein engineering at Kosan Biosciences before holding a staff scientist position at Applied Biosystems from 2005 to 2006, focusing on engineering of DNA polymerases. In 2007, Dr. Welch joined DNA2.0 as director of gene design to develop the company’s capabilities in the areas of protein expression and engineering. He has more than 15 years experience in directed evolution and engineering of nucleic acid and protein biomolecules.
DNAvaccine.com Presents: Optimizing Gene Expression/Performance using GeneGPS™
Tuesday, May 22, 2012
1:00 PM – 2:00 PM EDT
After registering you will receive a confirmation email containing information about joining the Webinar.
Required: Windows® 7, Vista, XP or 2003 Server
Required: Mac OS® X 10.5 or newer